{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:24:41Z","timestamp":1778909081406,"version":"3.51.4"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2014270S"],"award-info":[{"award-number":["A2014270S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS065069"],"award-info":[{"award-number":["NS065069"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0200251","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T13:49:19Z","timestamp":1530884959000},"page":"e0200251","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-9595","authenticated-orcid":true,"given":"Thomas J.","family":"Esparza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihika","family":"Gangolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel J.","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WAD.0000000000000196","article-title":"Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia","volume":"31","author":"GS Day","year":"2017","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-017-0293-3","article-title":"Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease","volume":"9","author":"DL Brody","year":"2017","journal-title":"Alzheimer's research & therapy"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"TJ Esparza","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","article-title":"Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques","volume":"106","author":"RM Koffie","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 7","key":"ref5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta","volume":"135","author":"RM Koffie","year":"2012","journal-title":"Brain: a journal of neurology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"ST DeKosky","year":"1990","journal-title":"Ann Neurol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"RD Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"38187","DOI":"10.1038\/srep38187","article-title":"Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains","volume":"6","author":"TJ Esparza","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/01.WNL.0000098933.34804.FC","article-title":"Understanding of informed consent by demented individuals","volume":"61","author":"VD Buckles","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","article-title":"Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain","volume":"7","author":"NC Wildburger","year":"2017","journal-title":"Scientific reports"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3233\/JAD-2010-1331","article-title":"Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy","volume":"19","author":"JP Guo","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/bi992933h","article-title":"Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism","volume":"39","author":"WP Esler","year":"2000","journal-title":"Biochemistry"},{"issue":"32","key":"ref13","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi990718v","article-title":"Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations","volume":"38","author":"BP Tseng","year":"1999","journal-title":"Biochemistry"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-160453","article-title":"Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-beta","volume":"55","author":"I Gureviciene","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2013.04.031","article-title":"Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics","volume":"440","author":"KG Mawuenyega","year":"2013","journal-title":"Anal Biochem"},{"issue":"51","key":"ref16","doi-asserted-by":"crossref","first-page":"15157","DOI":"10.1021\/bi061850f","article-title":"Solution state characterization of amyloid beta-derived diffusible ligands","volume":"45","author":"RW Hepler","year":"2006","journal-title":"Biochemistry"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(02)00050-5","article-title":"Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets","volume":"41","author":"WL Klein","year":"2002","journal-title":"Neurochem Int"},{"issue":"7233","key":"ref18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"J Lauren","year":"2009","journal-title":"Nature"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"M Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"ref20","doi-asserted-by":"crossref","first-page":"32895","DOI":"10.1074\/jbc.M109.000208","article-title":"Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains","volume":"284","author":"A Noguchi","year":"2009","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0200251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:21:59Z","timestamp":1540232519000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0200251"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0200251","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/227009","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]}}}